[Clinical trial of coenzyme A in hepatopathies].
Coenzyme A (900 L.U. i.v.) was administered for 20 days in 18 cases of viral hepatitis, 2 of chronic ethylic hepatosis, and 5 of ascitic portal cirrhosis. Blood lactic acid, pyruvic acid, serum transaminase and beta/alpha lipoprotein ratio were determined. BSF and colloidal serolability tests were also carried out. The benefits of coenzyme A treatment were particularly indicated by the significant changes noted in lactic and pyruvic acid values.
D000293:Adolescent; D000328:Adult; D000437:Alcoholism / Q000150:complications; D003065:Coenzyme A / Q000627:therapeutic use*; D005234:Fatty Liver / Q000188:drug therapy; D006506:Hepatitis A / Q000188:drug therapy; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy; D008107:Liver Diseases / Q000175:diagnosis / Q000188:drug therapy*; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged
D003065:Coenzyme A
Spermintazione clinica del coenzima A in corso di epatopatie